Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Raltegravir Intensification for HAND
NCT01448486Phase 4Terminated
- Sponsor
- St Vincent's Hospital
- Start
- Oct 2011
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in HIV-associated neurocognitive disorders (HAND) comparing Raltegravir Intensification with Standard of Care HAART (2 arms). Primary endpoint: Neurocognitive Function at 12 months. Started Oct 2011; status: terminated.
02
Drugs
raltegravir
03
Conditions
HIV-associated neurocognitive disorders (HAND)
Beyond the preview
Go deeper on NCT01448486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01448486.